Angewandte Chemie (International ed. in English) · 2025
Autocatalytic Electrochemiluminescence.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Asenjo Claudia Martinez, Petrini Francesco, Fracassa Alessandro, Knežević Sara, D'Arrigo Elisa, Francis Paul S, Paolucci Francesco, Sojic Neso, Kanoufi Frédéric, Valenti Giovanni
Аннотация
Electrochemiluminescence (ECL) is a powerful analytical technique that generates light through electrochemically induced reactions, enabling ultrasensitive biosensing and imaging of submicrometric objects. Conventional ECL systems, such as those using Ru(bpy)3 2⁺ and tri-n-propylamine (TPrA), require high applied potentials (oxidation at ∼1.4 V versus Ag/AgCl), leading to electrode surface modification and parasitic reactions. Herein, we present a novel autocatalytic ECL mechanism that drastically lowers the triggering potential to -0.2 V by exploiting the synergistic interplay between oxalate (C2O4 2-) and peroxydisulfate (S2O8 2-) radicals, mediated by Ru(NH3)6 3+ reduction. This system generates ECL without direct oxidation of the luminophore, but instead through a mild reduction process, relying on homogeneous radical reactions (SO4 • - and CO2 • -) to populate the Ru(bpy)3 2⁺* excited state. Experimental investigation at different Ru(NH3)6 3+/S2O8 2 -/C2O4 2 - concentration ratios, backed by finite element simulations, demonstrates the autocatalytic cycle's capability of exciting luminophores with a bandgap as high as 2.77 eV (blue-emitting Ir(III) complex), while also showing a more stable ECL emission and achieving an emitting layer as thick as ∼4.8 ± 0.2 µm. These findings establish a low-potential ECL pathway with a large emitting layer, extending the applicability of such nontoxic coreactants-historically limited by their short-lived radicals-and potentially paving the way for new frontiers in ECL.